RHEB and acute myeloid leukemia: Mechanistically, it has been found that the dual inhibitory effect of impaired Ras homolog enriched in brain (RHEB) prenylation by statins and CHR2863-induced mTOR inhibition achieves a potent synergistic inhibition on human AML cells [108].